Literature DB >> 17023119

The role of triiodothyronine-induced substrate cycles in the hepatic response to overnutrition: thyroid hormone as an antioxidant.

Neville Grant1.   

Abstract

Overnutrition, by generating reactive oxygen species (ROS), produces oxidative stress - an important cause of cellular injury. In the liver, overnutrition begins in the perivenous hepatocytes. To prevent injury, cells must protect themselves against ROS accumulation. Overnutrition also activates the enzyme deiodinase-1 (D1), which catalyzes the conversion of T4 to T3. D1 is primarily located in the PV region of the liver. Thyroid hormone is known to generate substrate cycling. The hypothesis of this paper is that a nutrient-induced increase in intracellular T3 acts as an antioxidant by inducing substrate cycles that reduce ROS accumulation. These cycles do this by: (i) reducing ROS formation by hydrolyzing excess ATP, thus enhancing oxidative phosphorylation and reducing the proton motive force on the electron transport chain (ETC), and; (ii) enhancing the removal (reduction) of ROS by producing the NADPH required for regeneration of reduced glutathione, a potent endogenous antioxidant. Oxidative stress is an important factor in the etiology of a number of hepatic injuries, including nonalcoholic steatohepatitis (NASH) and hepatocarcinogenesis. In the latter, the frequency of mutations in thyroid hormone receptors (TRs) supports the concept that thyroid hormone acts as a tumor suppressor by reducing oxidative stress. This paper reviews the substrate cycles involved in this process. It also describes other mechanisms that permit rapid availability of T3 to cells undergoing oxidative stress.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17023119     DOI: 10.1016/j.mehy.2006.07.045

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  6 in total

1.  Changes of activity and kinetics of certain liver and heart enzymes of hypothyroid and T(3)-treated rats.

Authors:  Urszula Czyzewska; Adam Tylicki; Magdalena Siemieniuk; Slawomir Strumilo
Journal:  J Physiol Biochem       Date:  2012-01-25       Impact factor: 4.158

2.  Thymoquinone Ameliorate Hepatorenal Toxicity Associated With Propylthiouracil-Induced Hypothyroidism in Juvenile Rats.

Authors:  Y Baghcheghi; A Mokhtari-Zaer; M Hosseini; A Anaeigoudari; H Salmani; F Beheshti
Journal:  Acta Endocrinol (Buchar)       Date:  2021 Oct-Dec       Impact factor: 1.104

Review 3.  Thyroid Hormone Mediated Modulation of Energy Expenditure.

Authors:  Janina A Vaitkus; Jared S Farrar; Francesco S Celi
Journal:  Int J Mol Sci       Date:  2015-07-16       Impact factor: 5.923

Review 4.  Nonalcoholic fatty liver disease: molecular pathways and therapeutic strategies.

Authors:  Yue Ye Huang; Aaron M Gusdon; Shen Qu
Journal:  Lipids Health Dis       Date:  2013-11-09       Impact factor: 3.876

5.  Thyroid Hormone-Regulated Expression of Period2 Promotes Liver Urate Production.

Authors:  Xiaoting Chen; Mian Wu; Nan Liang; Junxi Lu; Shen Qu; Haibing Chen
Journal:  Front Cell Dev Biol       Date:  2021-04-01

6.  Mice lacking thyroid hormone receptor Beta show enhanced apoptosis and delayed liver commitment for proliferation after partial hepatectomy.

Authors:  Raquel López-Fontal; Miriam Zeini; Paqui G Través; Mariana Gómez-Ferrería; Ana Aranda; Guillermo T Sáez; Concha Cerdá; Paloma Martín-Sanz; Sonsoles Hortelano; Lisardo Boscá
Journal:  PLoS One       Date:  2010-01-14       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.